Shareholders’ Equity and Equity Compensation - Schedule of Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Compensation recognized	$ 28,293	$ 4,485	$ 42,984	$ 8,943
Cost of Sales | Cost of services - Molecular profiling services
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Compensation recognized	882	399	1,348	826
Cost of Sales | Cost of services - Pharma research and development services
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Compensation recognized	2	2	3	4
Selling and marketing expense
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Compensation recognized	1,990	967	3,232	2,085
General and administrative expense
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Compensation recognized	22,392	2,053	33,027	3,998
Research and development expense
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Compensation recognized	$ 3,027	$ 1,064	$ 5,374	$ 2,030